Therapeutic Nuclear Medicines Industry Research Report 2024
This report aims to provide a comprehensive presentation of the global market for Therapeutic Nuclear Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Nuclear Medicines.
The Therapeutic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Therapeutic Nuclear Medicines type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Therapeutic Nuclear Medicines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Therapeutic Nuclear Medicines segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Therapeutic Nuclear Medicines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Therapeutic Nuclear Medicines market.
Therapeutic Nuclear Medicines segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Therapeutic Nuclear Medicines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Therapeutic Nuclear Medicines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Medicines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Nuclear Medicines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Nuclear Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The Therapeutic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Novartis AG
- Bayer
- China Isotope & Radiation
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Dongcheng
- Lantheus
- Acrotech Biopharma.
- Progenics Pharmaceuticals
- International Isotopes
Global markets are presented by Therapeutic Nuclear Medicines type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Therapeutic Nuclear Medicines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Therapeutic Nuclear Medicines segment by Type
- Radium-223
- Lutetium-177
- Iodine-131
- Other
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Therapeutic Nuclear Medicines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Therapeutic Nuclear Medicines market.
Therapeutic Nuclear Medicines segment by Application
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Therapeutic Nuclear Medicines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Therapeutic Nuclear Medicines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Medicines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Nuclear Medicines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Nuclear Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Therapeutic Nuclear Medicines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Therapeutic Nuclear Medicines Sales (2019-2030)
2.2.3 Global Therapeutic Nuclear Medicines Market Average Price (2019-2030)
2.3 Therapeutic Nuclear Medicines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
2.4 Therapeutic Nuclear Medicines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Thyroid
2.4.3 Bone Metastasis
2.4.4 Lymphoma
2.4.5 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Therapeutic Nuclear Medicines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Therapeutic Nuclear Medicines Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Therapeutic Nuclear Medicines Revenue of Manufacturers (2019-2024)
3.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2019-2024)
3.5 Global Therapeutic Nuclear Medicines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Therapeutic Nuclear Medicines, Product Type & Application
3.8 Global Manufacturers of Therapeutic Nuclear Medicines, Date of Enter into This Industry
3.9 Global Therapeutic Nuclear Medicines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Novartis AG
4.1.1 Novartis AG Company Information
4.1.2 Novartis AG Business Overview
4.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
4.1.5 Novartis AG Recent Developments
4.2 Bayer
4.2.1 Bayer Company Information
4.2.2 Bayer Business Overview
4.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
4.2.5 Bayer Recent Developments
4.3 China Isotope & Radiation
4.3.1 China Isotope & Radiation Company Information
4.3.2 China Isotope & Radiation Business Overview
4.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
4.3.5 China Isotope & Radiation Recent Developments
4.4 Q BioMed
4.4.1 Q BioMed Company Information
4.4.2 Q BioMed Business Overview
4.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
4.4.5 Q BioMed Recent Developments
4.5 Curium Pharmaceuticals
4.5.1 Curium Pharmaceuticals Company Information
4.5.2 Curium Pharmaceuticals Business Overview
4.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
4.5.5 Curium Pharmaceuticals Recent Developments
4.6 Jubilant DraxImage
4.6.1 Jubilant DraxImage Company Information
4.6.2 Jubilant DraxImage Business Overview
4.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
4.6.5 Jubilant DraxImage Recent Developments
4.7 Dongcheng
4.7.1 Dongcheng Company Information
4.7.2 Dongcheng Business Overview
4.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
4.7.5 Dongcheng Recent Developments
4.8 Lantheus
4.8.1 Lantheus Company Information
4.8.2 Lantheus Business Overview
4.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
4.8.5 Lantheus Recent Developments
4.9 Acrotech Biopharma.
4.9.1 Acrotech Biopharma. Company Information
4.9.2 Acrotech Biopharma. Business Overview
4.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
4.9.5 Acrotech Biopharma. Recent Developments
4.10 Progenics Pharmaceuticals
4.10.1 Progenics Pharmaceuticals Company Information
4.10.2 Progenics Pharmaceuticals Business Overview
4.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
4.10.5 Progenics Pharmaceuticals Recent Developments
6.11 International Isotopes
6.11.1 International Isotopes Company Information
6.11.2 International Isotopes Therapeutic Nuclear Medicines Business Overview
6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
6.11.5 International Isotopes Recent Developments
5 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET SCENARIO BY REGION
5.1 Global Therapeutic Nuclear Medicines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Therapeutic Nuclear Medicines Sales by Region: 2019-2030
5.2.1 Global Therapeutic Nuclear Medicines Sales by Region: 2019-2024
5.2.2 Global Therapeutic Nuclear Medicines Sales by Region: 2025-2030
5.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2030
5.3.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2024
5.3.2 Global Therapeutic Nuclear Medicines Revenue by Region: 2025-2030
5.4 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.4.1 North America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.4.3 North America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.5.1 Europe Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.5.3 Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.6.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.6.3 Asia Pacific Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.7.1 Latin America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.7.3 Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.8.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030)
6.1.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030) & (K Units)
6.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)
6.2 Global Therapeutic Nuclear Medicines Revenue by Type (2019-2030)
6.2.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)
6.3 Global Therapeutic Nuclear Medicines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030)
7.1.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030) & (K Units)
7.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)
7.2 Global Therapeutic Nuclear Medicines Revenue by Application (2019-2030)
6.2.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)
7.3 Global Therapeutic Nuclear Medicines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Therapeutic Nuclear Medicines Value Chain Analysis
8.1.1 Therapeutic Nuclear Medicines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Therapeutic Nuclear Medicines Production Mode & Process
8.2 Therapeutic Nuclear Medicines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Therapeutic Nuclear Medicines Distributors
8.2.3 Therapeutic Nuclear Medicines Customers
9 GLOBAL THERAPEUTIC NUCLEAR MEDICINES ANALYZING MARKET DYNAMICS
9.1 Therapeutic Nuclear Medicines Industry Trends
9.2 Therapeutic Nuclear Medicines Industry Drivers
9.3 Therapeutic Nuclear Medicines Industry Opportunities and Challenges
9.4 Therapeutic Nuclear Medicines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Therapeutic Nuclear Medicines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Therapeutic Nuclear Medicines Sales (2019-2030)
2.2.3 Global Therapeutic Nuclear Medicines Market Average Price (2019-2030)
2.3 Therapeutic Nuclear Medicines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
2.4 Therapeutic Nuclear Medicines by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Thyroid
2.4.3 Bone Metastasis
2.4.4 Lymphoma
2.4.5 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Therapeutic Nuclear Medicines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Therapeutic Nuclear Medicines Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Therapeutic Nuclear Medicines Revenue of Manufacturers (2019-2024)
3.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2019-2024)
3.5 Global Therapeutic Nuclear Medicines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Therapeutic Nuclear Medicines, Product Type & Application
3.8 Global Manufacturers of Therapeutic Nuclear Medicines, Date of Enter into This Industry
3.9 Global Therapeutic Nuclear Medicines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Novartis AG
4.1.1 Novartis AG Company Information
4.1.2 Novartis AG Business Overview
4.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
4.1.5 Novartis AG Recent Developments
4.2 Bayer
4.2.1 Bayer Company Information
4.2.2 Bayer Business Overview
4.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
4.2.5 Bayer Recent Developments
4.3 China Isotope & Radiation
4.3.1 China Isotope & Radiation Company Information
4.3.2 China Isotope & Radiation Business Overview
4.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
4.3.5 China Isotope & Radiation Recent Developments
4.4 Q BioMed
4.4.1 Q BioMed Company Information
4.4.2 Q BioMed Business Overview
4.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
4.4.5 Q BioMed Recent Developments
4.5 Curium Pharmaceuticals
4.5.1 Curium Pharmaceuticals Company Information
4.5.2 Curium Pharmaceuticals Business Overview
4.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
4.5.5 Curium Pharmaceuticals Recent Developments
4.6 Jubilant DraxImage
4.6.1 Jubilant DraxImage Company Information
4.6.2 Jubilant DraxImage Business Overview
4.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
4.6.5 Jubilant DraxImage Recent Developments
4.7 Dongcheng
4.7.1 Dongcheng Company Information
4.7.2 Dongcheng Business Overview
4.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
4.7.5 Dongcheng Recent Developments
4.8 Lantheus
4.8.1 Lantheus Company Information
4.8.2 Lantheus Business Overview
4.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
4.8.5 Lantheus Recent Developments
4.9 Acrotech Biopharma.
4.9.1 Acrotech Biopharma. Company Information
4.9.2 Acrotech Biopharma. Business Overview
4.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
4.9.5 Acrotech Biopharma. Recent Developments
4.10 Progenics Pharmaceuticals
4.10.1 Progenics Pharmaceuticals Company Information
4.10.2 Progenics Pharmaceuticals Business Overview
4.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
4.10.5 Progenics Pharmaceuticals Recent Developments
6.11 International Isotopes
6.11.1 International Isotopes Company Information
6.11.2 International Isotopes Therapeutic Nuclear Medicines Business Overview
6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
6.11.5 International Isotopes Recent Developments
5 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET SCENARIO BY REGION
5.1 Global Therapeutic Nuclear Medicines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Therapeutic Nuclear Medicines Sales by Region: 2019-2030
5.2.1 Global Therapeutic Nuclear Medicines Sales by Region: 2019-2024
5.2.2 Global Therapeutic Nuclear Medicines Sales by Region: 2025-2030
5.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2030
5.3.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2024
5.3.2 Global Therapeutic Nuclear Medicines Revenue by Region: 2025-2030
5.4 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.4.1 North America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.4.3 North America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.5.1 Europe Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.5.3 Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.6.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.6.3 Asia Pacific Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.7.1 Latin America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.7.3 Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country
5.8.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030)
6.1.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030) & (K Units)
6.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)
6.2 Global Therapeutic Nuclear Medicines Revenue by Type (2019-2030)
6.2.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)
6.3 Global Therapeutic Nuclear Medicines Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030)
7.1.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030) & (K Units)
7.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)
7.2 Global Therapeutic Nuclear Medicines Revenue by Application (2019-2030)
6.2.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)
7.3 Global Therapeutic Nuclear Medicines Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Therapeutic Nuclear Medicines Value Chain Analysis
8.1.1 Therapeutic Nuclear Medicines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Therapeutic Nuclear Medicines Production Mode & Process
8.2 Therapeutic Nuclear Medicines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Therapeutic Nuclear Medicines Distributors
8.2.3 Therapeutic Nuclear Medicines Customers
9 GLOBAL THERAPEUTIC NUCLEAR MEDICINES ANALYZING MARKET DYNAMICS
9.1 Therapeutic Nuclear Medicines Industry Trends
9.2 Therapeutic Nuclear Medicines Industry Drivers
9.3 Therapeutic Nuclear Medicines Industry Opportunities and Challenges
9.4 Therapeutic Nuclear Medicines Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
